Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00338312 · ClinicalTrials.gov registry record · Phase 3
Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
A Phase 3 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 3
- Development phase
- 610
- Enrollment target
NCT00338312: Completed Phase 3 study, sponsored by Warner Chilcott.
NCT00338312 is a Phase 3 study that has completed, run by Warner Chilcott. The registered enrollment target is 610 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00338312, a Phase 3 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 610 participants
- Enrollment target
Study Summary
This study is designed to evaluate efficacy and safety of a testosterone patch as treatment for low libido in naturally menopausal women who are taking estrogen or estrogen/progestin therapy.
Interventions
- DRUG Placebo patch
- DRUG Testosterone Transdermal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2002-06 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
What the finished NCT00338312 record still lists
NCT00338312 is an interventional study that assigns participants to a tested intervention. The registered 610 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo patch is the first listed.
NCT00338312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00338312 about?
NCT00338312 is a clinical study titled "Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido". This study is designed to evaluate efficacy and safety of a testosterone patch as treatment for low libido in naturally menopausal women who are taking estrogen or estrogen/progestin therapy.
What is the current status of trial NCT00338312?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 610 participants. The study started on 2002-06. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00338312?
The interventions under investigation include: Placebo patch (DRUG), Testosterone Transdermal System (DRUG).
Who is sponsoring clinical trial NCT00338312?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00338312's enrollment target sits among peer trials
610 601st of 2000 higher than 1,399 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03536312 · 610 participants · NA
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
- NCT05838638 · 610 participants · NA
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
- NCT07075718 · 610 participants · Phase 2
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia